S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Genomma Lab Reports Mixed Q2 2026 Results Amid Market Recovery

Genomma Lab Internacional reported a 3.6% decline in like-for-like sales for the second quarter of 2026, as the company navigated a soft retail environment in Mexico and the US. Despite the top-line contraction, the pharmaceutical group managed a 5.5% increase in net income, bolstered by improved margins and reduced financial expenses.

Genomma Lab Reports Mixed Q2 2026 Results Amid Market Recovery
Photo: Bio & News

CEO Marco Sparvieri noted that while the company faced continued market headwinds, its core business units maintained or expanded market share. The gross margin saw a 106 basis-point improvement, reaching 64.6%, as productivity gains effectively absorbed higher promotional spending and new tax burdens on sweetened beverages. Performance varied by region, with Latin American operations recording 3.9% growth, which partially offset the ongoing disruption within the US Hispanic market.

Consolidated net sales totaled 4,397 million Mexican pesos, reflecting a 6.0% decrease compared to the same period in 2025, a figure further impacted by the 10.8% appreciation of the Mexican peso. While operating income and EBITDA faced pressure due to operational deleverage, the company remains optimistic about a second-half recovery. This confidence is driven by a new innovation pipeline, including the rollout of Suerox Mineral, which has already shown positive sell-out trends in early July. Management will discuss these results and future outlook during a scheduled conference call on July 23.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!